Get notified when PHGE files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsBiomX appoints Roy Rousso as Chief Business Officer with $143K annual fee and 200K shares
Filed May 28, 2026 · Period ending May 27, 2026 · ~1 min read
Key Changes
-
medium
Roy Rousso appointed Chief Business Officer effective July 1, 2026, bringing two decades of digital infrastructure and technology leadership experience from roles including Head of Global Business Development at Flexnode.
Item 5.02 verify on EDGAR → -
medium
Rousso to receive 200,000 shares vesting equally over three years, subject to Board approval of new equity incentive plan. Accelerated vesting applies if terminated without cause or upon change of control.
Item 5.02 verify on EDGAR → -
low
Compensation structured as consulting arrangement at 70% engagement: $11,900 monthly ($143K annually) plus potential 50% performance bonus based on Board-established milestones.
Item 5.02 verify on EDGAR →
1 more material change behind this preview — plus the full narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.
Want to see a complete report first? Today's free report (ADMT 10-K) is open in full — no account needed.
Partner
Trade PHGE commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Thanks — your feedback helps us improve report quality.
Source-verified from EDGAR · Narrative written by AI · May 28, 2026 · How we verify